Remedium
Boston, US · 1 known investors
Remedium is a biotechnology company developing gene therapies based on its Prometheus adjustable gene therapy platform, which delivers therapeutic genes via a single subcutaneous injection with post-treatment dose adjustment. Its pipeline targets diseases of aging and large unmet clinical needs across endocrinology (weight loss and type 2 diabetes), immunology, neurology, and musculoskeletal diseases.